Jul 15, 2026 04:05PM
Jul 14, 2026 04:05PM
Jun 15, 2026 01:30AM
May 28, 2026 04:06PM
May 28, 2026 04:05PM
May 20, 2026 04:05PM
May 19, 2026 04:05PM QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 12, 2026 02:00AM
May 7, 2026 06:00AM
May 6, 2026 04:05PM
Apr 27, 2026 04:16PM
Apr 27, 2026 04:16PM
Apr 16, 2026 04:05PM
Apr 14, 2026 04:05PM QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
Mar 19, 2026 04:05PM
Mar 10, 2026 05:05PM
Feb 19, 2026 08:00AM
Feb 4, 2026 04:05PM
Feb 3, 2026 04:05PM
Jan 26, 2026 04:05PM
Jan 12, 2026 02:00AM QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
Dec 18, 2025 11:27AM
Dec 18, 2025 11:27AM
Nov 10, 2025 01:30AM
Nov 4, 2025 01:04PM
Nov 4, 2025 01:04PM
Aug 5, 2025 04:05PM
Jun 26, 2025 01:16PM QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
May 7, 2025 04:05PM
Feb 5, 2025 04:05PM
Jan 16, 2025 04:05PM
Jan 12, 2025 01:05PM
Nov 3, 2021 04:08PM
Jul 29, 2021 04:14PM
Jul 12, 2021 11:16AM Qiagen (QGEN) announces preliminary Q2 2021 results exceeding outlook; plans new $100 million share repurchase program
Jul 12, 2021 11:15AM
Mar 2, 2020 08:19AM
Jan 9, 2020 04:05PM
Oct 7, 2019 04:06PM
Oct 7, 2019 04:05PM
Sep 10, 2019 01:30AM
Jul 24, 2019 04:09PM QIAGEN Reports Results for Second Quarter of 2019; Updates Full-Year 2019 Outlook Due to Decision to Restructure China NGS Partnership
May 10, 2019 01:30AM
May 6, 2019 04:05PM
May 15, 2018 02:00AM
Jan 31, 2018 04:10PM
Nov 6, 2017 04:05PM
Jan 26, 2017 02:09AM
Jan 25, 2017 02:00PM QIAGEN Announces Adjustment of Conversion Ratio Under its 0.375% Senior Unsecured Convertible Notes due 2019 (ISIN XS1046477235)
Jan 18, 2017 04:14PM

101,050 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All